Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT/mTOR/SREBP-2 pathway - Dong, X; Zhu, Y; Wang, S; Luo, Y; Lu, S; Nan, F (Int Immunopharmacol, 2020)